Key result
Obesity may act as a critical confounder in the association between vitamin D deficiency and cardiovascular disease, suggesting supplementation might only benefit obese adults at increased CVD risk.
Why the study?
Despite strong associations between vitamin D deficiency and cardiovascular outcomes, supplementation trials in the general population have failed to reduce cardiovascular events and mortality.
Does vitamin D supplementation reduce cardiovascular events and mortality in the general population and obese adults?
Does vitamin D supplementation reduce cardiovascular events and mortality in the general population and obese adults?
Obesity may confound the relationship between vitamin D deficiency and cardiovascular disease, suggesting that targeted supplementation might only benefit obese adults at increased CVD risk rather than the general population.
Authors
No takes yet. Share an insight, caveat, or question.
Should not change vitamin D supplementation practice; leaves open need for obesity-stratified RCTs on CVD outcomes.
Paschou et al. (2019) conducted a review in Cardiovascular disease and vitamin D deficiency. Vitamin D deficiency and obesity was evaluated. Obesity may act as a critical confounder in the association between vitamin D deficiency and cardiovascular disease, suggesting supplementation might only benefit obese adults at increased CVD risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: